▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...
InnovationOpenLab

PsychoGenics Launches an Updated Corporate Identity and Brand

PsychoGenics Inc. (“PsychoGenics” or the “Company”), the leading contract research organization (CRO) specializing in central nervous system (CNS) focused preclinical and translational drug di...

Business Wire

Coinciding with the Society for Neuroscience meeting, the company rolls out a new logo and tagline, website, and booth (#2201)

PARAMUS, N.J.: PsychoGenics Inc. (“PsychoGenics” or the “Company”), the leading contract research organization (CRO) specializing in central nervous system (CNS) focused preclinical and translational drug discovery services, is proud to unveil its refreshed corporate identity and brand. The change underscores the Company’s deep expertise and customized solutions dedicated to discovering breakthrough CNS treatments for biopharmaceutical companies, disease research foundations and government agencies.

The rebranding initiative aligns with the Society for Neuroscience (SfN) annual meeting 2023 taking place in Washington D.C. November 11-15 at the Walter E. Washington Convention Center. PsychoGenics will actively participate by exhibiting at booth # 2201 and presenting multiple posters showcasing its advancements in discovery and translational neuroscience.

Emer Leahy, Ph.D. President and CEO, PsychoGenics remarked, “Our mission is to help our clients and partners identify breakthrough treatments for severely disabling CNS conditions. Since our inception in 1999, we have taken pride in our contributions, working with hundreds of companies, foundations and Government agencies, and testing a countless small molecules and gene therapies that have led to advancements in the treatment of many CNS disorders. Our new brand expresses the essence of our identity and mission.”

In conjunction with the rebrand, the Company has launched a redesigned website that mirrors its fresh identity https://www.psychogenics.com/. Additionally, a new video has been introduced, providing insights into the Company’s AI-enabled phenotypic approach to drug discovery https://www.psychogenics.com/in-vivo-ai-platforms/.

About PsychoGenics

PsychoGenics Inc. and its discovery arm, PGI Drug Discovery LLC (collectively known as PsychoGenics), have pioneered the translation of rodent behavioral and physiological responses into robust, high-throughput and high-content phenotyping. PsychoGenics’ drug discovery platforms, SmartCube®, NeuroCube®, PhenoCube® and eCube®, have been used in shared-risk partnerships with major pharmaceutical companies, including Sunovion, Roche and Karuna, resulting in the discovery of several novel compounds now in clinical trials or advanced preclinical development. PsychoGenics’ capabilities also include standard behavioral testing, electrophysiology, translational EEG, molecular biology, microdialysis and quantitative immunohistochemistry. In addition, the Company offers a variety of mouse models that support research in areas such as Huntington’s disease, autism spectrum disorders, psychosis/schizophrenia, depression, PTSD, Alzheimer’s disease, Parkinson’s disease, muscular dystrophy, ALS, seizure disorders and pain.

Contacts

Dr. Emer Leahy
President & CEO
(914) 406-8008
emer.leahy@psychogenics.com

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Metaverse: between fashion, ecommerce and real estate in Italy strong…

The European market for the metaverse will generate $119.35 billion in revenue. Companies must make themselves ready.

Italy's Space Economy ecosystem looks to the Moon

Italian Space Agency is developing a lunar habitation module that could be used in the NASA Artemis Space exploration program

Bravo Innovation Hub Palermo: 20 startups selected for acceleration

The acceleration program developed by MIMIT selected the best startups for the “New energy, green and clean tech” and “Inclusion, social impact and Health”…

Italian system integrator Var Group expands digital security services…

With the acquisition of 51% of the South Tyrolean company ICS, the business unit Digital Security will also strengthen its Security Operation Center

Most read

Italian system integrator Var Group expands digital security services…

With the acquisition of 51% of the South Tyrolean company ICS, the business unit Digital Security will also strengthen its Security Operation Center

Italy's Space Economy ecosystem looks to the Moon

Italian Space Agency is developing a lunar habitation module that could be used in the NASA Artemis Space exploration program

Metaverse: between fashion, ecommerce and real estate in Italy strong…

The European market for the metaverse will generate $119.35 billion in revenue. Companies must make themselves ready.

BrainChip Attracts Former Intel AI Sales Executive to Head Up Sales

BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!